tiprankstipranks
Corvus Pharmaceuticals Inc (DE:C17)
FRANKFURT:C17

Corvus Pharmaceuticals (C17) Stock News & Sentiment

0 Followers
Corvus Pharmaceuticals Announces Initiation of Placebo-Controlled Phase 1 Clinical Trial of Soquelitinib for Atopic Dermatitis
PremiumPress Releases
Corvus Pharmaceuticals Announces Initiation of Placebo-Controlled Phase 1 Clinical Trial of Soquelitinib for Atopic Dermatitis
8d ago
Corvus Pharmaceuticals: Insider Ownership Raises Power Concentration Concerns
PremiumCompany Announcements
Corvus Pharmaceuticals: Insider Ownership Raises Power Concentration Concerns
28d ago
Corvus Pharmaceuticals Provides Business Update and Reports Fourth Quarter and Full Year 2023 Financial Results
PremiumPress Releases
Corvus Pharmaceuticals Provides Business Update and Reports Fourth Quarter and Full Year 2023 Financial Results
29d ago
Options Volatility and Implied Earnings Moves Today, March 19, 2024
PremiumMarket News
Options Volatility and Implied Earnings Moves Today, March 19, 2024
30d ago
Corvus Pharmaceuticals to Provide Business Update and Fourth Quarter and Full Year 2023 Financial Results on March 19, 2024
PremiumPress Releases
Corvus Pharmaceuticals to Provide Business Update and Fourth Quarter and Full Year 2023 Financial Results on March 19, 2024
1M ago
CRVS Earnings Report this Week: Is It a Buy, Ahead of Earnings?
PremiumPre-Earnings
CRVS Earnings Report this Week: Is It a Buy, Ahead of Earnings?
1M ago
Corvus Pharmaceuticals Presents Soquelitinib Preclinical Data at the Keystone Symposia on Systemic Autoimmune and Autoinflammatory Diseases
PremiumPress Releases
Corvus Pharmaceuticals Presents Soquelitinib Preclinical Data at the Keystone Symposia on Systemic Autoimmune and Autoinflammatory Diseases
2M ago
More CRVS News >

News Score - Last 7 Days

Neutral
DE:C17
Sector Average
Media Buzz
This Week2 articles
Weekly Average2.25 articles
News Sentiment
This Week50%
Sector Average65%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is DE:C17’s Media Buzz Sentiment?
2 articles about DE:C17 were published this week. In an average week, 2.25 articles are published.
    What is DE:C17’s weekly average amount of articles?
    In an average week, 2.25 articles about DE:C17 are published.
      What is DE:C17’s News Sentiment?
      50% of articles about DE:C17 were positive this week, compared to its sector average of 65%.
        Healthcare Stocks that are Trending in the News
        0HNZFagron SA
        ALPNAlpine Immune Sciences
        JANXJanux Therapeutics Inc
        MRNSMarinus
        EWEdwards Lifesciences
        Showing the stocks with the most bullish news sentiment over the past week
        What's Included in PREMIUM?
        Make informed decisions based on Top Analysts' activity
        Know what industry insiders are buying
        Get actionable alerts from top Wall Street Analysts
        Find out before anyone else which stock is going to shoot up
        Get powerful stock screeners & detailed portfolio analysis